Charles F. Wagner Jr - Mar 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Mar 10, 2023
Transactions value $
-$1,388,054
Form type
4
Date filed
3/14/2023, 04:22 PM
Previous filing
Feb 28, 2023
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale -$103K -361 -0.62% $286.64 57.8K Mar 10, 2023 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$148K -515 -0.89% $287.83 57.3K Mar 10, 2023 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$94.5K -327 -0.57% $288.91 56.9K Mar 10, 2023 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$8.68K -30 -0.05% $289.44 56.9K Mar 10, 2023 Direct F1
transaction VRTX Common Stock Sale -$158K -541 -0.95% $291.47 56.4K Mar 10, 2023 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$54.1K -185 -0.33% $292.68 56.2K Mar 10, 2023 Direct F1, F2, F7
transaction VRTX Common Stock Sale -$7.93K -27 -0.05% $293.61 56.1K Mar 10, 2023 Direct F1
transaction VRTX Common Stock Sale -$30.1K -102 -0.18% $294.94 56K Mar 10, 2023 Direct F1, F2, F8
transaction VRTX Common Stock Sale -$6.92K -24 -0.04% $288.31 56K Mar 13, 2023 Direct F1
transaction VRTX Common Stock Sale -$123K -420 -0.76% $292.41 55.1K Mar 13, 2023 Direct F1, F2, F9
transaction VRTX Common Stock Sale -$338K -1.15K -2.07% $293.35 54.4K Mar 13, 2023 Direct F1, F2, F10
transaction VRTX Common Stock Sale -$211K -715 -1.31% $294.52 53.7K Mar 13, 2023 Direct F1, F2, F11
transaction VRTX Common Stock Sale -$86.4K -292 -0.54% $295.89 53.4K Mar 13, 2023 Direct F1, F2, F12
transaction VRTX Common Stock Sale -$18.4K -62 -0.12% $296.77 53.4K Mar 13, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1.
F2 Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $286.64 (range $286.17 to $287.16).
F4 Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.30 to $288.20).
F5 Open market sales reported on this line occurred at a weighted average price of $288.91 (range $288.37 to $289.34).
F6 Open market sales reported on this line occurred at a weighted average price of $291.47 (range $291.10 to $292.00).
F7 Open market sales reported on this line occurred at a weighted average price of $292.68 (range $292.14 to $293.12).
F8 Open market sales reported on this line occurred at a weighted average price of $294.94 (range $294.85 to $295.35).
F9 Open market sales reported on this line occurred at a weighted average price of $292.41 (range $291.97 to $292.82).
F10 Open market sales reported on this line occurred at a weighted average price of $293.35 (range $292.99 to $293.80).
F11 Open market sales reported on this line occurred at a weighted average price of $294.52 (range $294.13 to $294.81).
F12 Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.33 to $296.32).